Insider · CIK 0001240116

DE VAERE ROBERT J

Reports to the SEC for 2 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001240116

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-09-30	Horizon Therapeutics Public Ltd CoA Award	EVP & CFO	AAward	+112K sh	—	—	206,456
2014-09-30	Horizon Therapeutics Public Ltd CoS Sale	EVP & CFO	SSale	−51.9K sh	$12.28	−$638K	154,514
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−46.3K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−47.7K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−42.3K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−53.6K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−16.4K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−51K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−33.8K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−70K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−62K sh	—	—	0
2014-09-19	Horizon Therapeutics Public Ltd CoA Award	EVP & CFO	AAward	+94.3K sh	—	—	94,290
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	EVP & CFO	AAward	+46.3K sh	—	—	46,335
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	EVP & CFO	AAward	+47.7K sh	—	—	47,654
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	EVP & CFO	AAward	+42.3K sh	—	—	42,295
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	EVP & CFO	AAward	+53.6K sh	—	—	53,621
2014-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	EVP & CFO	AAward	+16.4K sh	—	—	16,416
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	EVP & CFO	AAward	+51K sh	—	—	51,000
2014-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	EVP & CFO	AAward	+33.8K sh	—	—	33,750
2014-09-19	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	EVP & CFO	AAward	+62K sh	—	—	62,000
2014-09-19	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)A Award	EVP & CFO	AAward	+70K sh	—	—	70,000
2014-09-19	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	EVP & CFO	DDisposition to Issuer	−94.3K sh	—	—	0
2014-01-02	Horizon Therapeutics Public Ltd CoRestricted stock unitsA Award	EVP & CFO	AAward	+62K sh	—	—	62,000
2014-01-02	Horizon Therapeutics Public Ltd CoEmployee stock options (right to buy)A Award	EVP & CFO	AAward	+70K sh	—	—	70,000
2013-12-09	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & CFO	MExercise/Conversion	+8,208 sh	—	—	90,244
2013-12-09	Horizon Therapeutics Public Ltd CoRestricted stock unitsM Exercise/Conversion	EVP & CFO	MExercise/Conversion	−8,208 sh	—	—	16,416
2013-12-05	Horizon Therapeutics Public Ltd CoA Award	EVP & CFO	AAward	+21.6K sh	—	—	82,036
2013-01-02	Horizon Therapeutics Public Ltd CoS Sale	EVP & CFO	SSale	−20.5K sh	$2.36	−$48.5K	51,092
2013-01-02	Horizon Therapeutics Public Ltd CoEmployee stock options (right to buy)A Award	EVP & CFO	AAward	+51K sh	—	—	51,000
2013-01-02	Horizon Therapeutics Public Ltd CoRestricted stock unitsA Award	EVP & CFO	AAward	+45K sh	—	—	45,000
2012-12-10	Horizon Therapeutics Public Ltd CoRestricted stock unitsM Exercise/Conversion	EVP & CFO	MExercise/Conversion	−8,208 sh	—	—	24,624
2012-12-10	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP & CFO	MExercise/Conversion	+8,208 sh	—	—	71,636
2012-07-26	Horizon Therapeutics Public Ltd CoA Award	EVP & CFO	AAward	+33K sh	—	—	60,391
2012-03-02	Horizon Therapeutics Public Ltd CoA Award	EVP & CFO	AAward	+22K sh	—	—	22,000
2011-12-08	Horizon Therapeutics Public Ltd CoRestricted stock unitsA Award	EVP & CFO	AAward	+32.8K sh	—	—	32,832
2011-12-08	Horizon Therapeutics Public Ltd CoEmployee stock options (right to buy)A Award	EVP & CFO	AAward	+53.6K sh	—	—	53,621
2005-08-16	IDM PHARMA, INC.Restricted Stock UnitsA Award	Sr. VP and CFO	AAward	+18.2K sh	—	—	18,171
2005-01-21	IDM PHARMA, INC.Incentive Stock Option (right to buy)A Award	Sr. VP and CFO	AAward	+20K sh	—	—	20,000
2003-09-08	IDM PHARMA, INC.Incentive Stock OptionA Award	Sr. VP and CFO	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Oct 24
Horizon Pharma plc0001181431-14-033367
SEC(opens sec.gov)
Sep 224
Horizon Pharma plc0001209191-14-059072
SEC(opens sec.gov)
Sep 224
Horizon Pharma plc0001209191-14-059111
SEC(opens sec.gov)

Companies

Address

C/O IDM PHARMA, INC 9 PARKER, SUITE 100

IRVINE, CA, 92618